Lake Street Advisors Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Lake Street Advisors Group's GILD Position: Q4 2024 in Review
Lake Street Advisors Group increased its Gilead Sciences (GILD) stake by 6.1% in Q4 2024, buying an estimated $97.1K and bringing the position to 18,852 shares worth $1.74M. The position accounts for 0.08% of the portfolio, ranked #158.
Lake Street Advisors Group first reported a position in GILD in Q4 2017 and has held it in 29 quarters since. The position peaked at $2.48M in Q2 2020. 1,888 funds tracked by Wall St. Rank hold GILD as of Q4 2024.
- Lake Street Advisors Group held 18,852 shares of Gilead Sciences worth $1.74M as of Q4 2024.
- Lake Street Advisors Group bought 1,078 Gilead Sciences shares in Q4 2024, an estimated $97.1K.
- Gilead Sciences made up 0.08% of Lake Street Advisors Group's portfolio in Q4 2024, its #158 holding.
- Lake Street Advisors Group first reported a position in Gilead Sciences in Q4 2017 and has held it in 29 quarters since.
- Lake Street Advisors Group's Gilead Sciences position peaked at $2.48M in Q2 2020.
- 1,888 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.
Based on Lake Street Advisors Group's 13F filing for Q4 2024, filed 4 Feb 2025.